Marker Share Price

Marker Share Price

NASDAQ: MRKR | Micro Cap | Healthcare
$1.10
-$0.22 (-16.67%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Marker Stock Performance

Open
$1.33
Prev. Close
$1.32
Circuit Range
N/A
Day Range
$1.09 - $1.41
Year Range
$0.81 - $2.44
Volume
21,078
Average Traded
$1.18

Marker Share Price Today

As of 21 November 2026, Marker Therapeutics, Inc.'s share price is $1.10. The stock opened at $1.33, compared to its previous close of $1.32. During today's trading session, Marker Therapeutics, Inc.'s share price traded between $1.09 and $1.41, with an average price of $1.25. Over the past 52 weeks, the stock has recorded a high of $2.44 and a low of $0.81. In terms of performance, Marker Therapeutics, Inc.'s share price has declined by 29.71% over the last six months and is down 10.93% on a year-on-year basis.

Marker Share Price Chart

Line chart of the Marker price trend over the selected period. The price fell overall, ranging from 1.09 to 1.41, ending at 1.10.
$1.09$1.41
L
Show Current Price
H

Marker Stock Fundamentals & Key Indicators

Market Cap
$16.84M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.51
Revenue (TTM)
$3.55B
Return On Equity (TTM)
-81.44%
Profit Margin
-342.54%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-8.24%

Marker Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.10$0.00$0.00$0.00
Net Profit-$1.70-$3.18-$1.83-$1.84
Net Profit Margin-154.55%N/AN/AN/A
Income ChangeN/A-87.06%42.45%-0.55%

Marker Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$3.51$3.31$6.59$3.55
Net Profit-$29.93-$8.24-$10.73-$12.16
Net Profit Margin-852.71%-248.94%-162.82%-342.54%
Income ChangeN/A72.47%-30.22%-13.33%

Marker Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.00.00.017.8
Current Assets19.0722.0217.1316.62
Total Assets19.0722.0217.1334.42
Non Current Liabilities0.00.00.05.26
Current Liabilities2.273.463.079.56
Total Liabilities2.273.463.0714.82
Shareholders' Equity16.818.5614.0519.6

Marker Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-12.01-10.91-16.44-26.97
Investing0.00.018.66-4.95
Financing9.8614.991.110.2

Corporate Actions

Split
Ex-date: 27 Jan 2023

About Marker

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Marker Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.93
$1.10
+13.40%
Oct 2026
$1.05
$0.97
-11.01%
Sep 2026
$1.32
$1.09
-24.83%
Aug 2026
$1.27
$1.45
+30.63%
Jul 2026
$1.47
$1.11
-25.50%
Jun 2026
$1.48
$1.49
-4.79%
May 2026
$1.46
$1.56
+10.60%
Apr 2026
$1.33
$1.42
+8.85%
Mar 2026
$1.46
$1.30
-12.16%
Feb 2026
$1.62
$1.48
-8.07%
Jan 2026
$1.53
$1.61
+10.27%
Dec 2025
$1.24
$1.46
+18.22%

Marker Share Price FAQs